Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Gross Profit (QoQ) (2009 - 2026)

Analysis

Charles River Laboratories International (CRL) Gross Profit (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 16.84%
Mar 28, 2026 -6.63%
Dec 27, 2025 -4.12%
Sep 27, 2025 -3.36%
Jun 28, 2025 9.96%
Mar 29, 2025 -38.06%
Dec 28, 2024 88.14%
Sep 28, 2024 -1.33%
Jun 29, 2024 2.57%
Mar 30, 2024 -50.38%
Dec 30, 2023 92.06%
Sep 30, 2023 -9.31%
Jul 1, 2023 5.65%
Apr 1, 2023 -23.97%
Dec 31, 2022 8.35%
Sep 24, 2022 1.76%
Jun 25, 2022 5.49%
Mar 26, 2022 -2.26%
Dec 25, 2021 2.27%
Sep 25, 2021 -2.41%